The overactive bladder market size is expected to grow at a CAGR of 2.52% during the forecast period of 2025-2034, driven by the rising prevalence and incidence of overactive bladder disorders and the introduction of novel treatment therapies across 8 major markets.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
2.52%
Value in USD Billion
2025-2034
Overactive Bladder Market Outlook
*this image is indicative*
Overactive bladder (OAB) is a medical condition that causes the frequent and sudden urge to urinate. It can result in unintentional loss of urine (urgency incontinence). Overactive bladder syndrome shows a high prevalence rate of 17% in adults. In children, the incidence of overactive bladder is nearly 16.6%. However, similar incidence rates are witnessed in men and women. The rising cases of the condition is anticipated to augment the overactive bladder market growth in the forecast period.
The surge in drugs and medical device approvals by health regulatory agencies is likely to impact the market dynamics positively. In August 2023, the United States Food and Drug Administration (FDA) granted marketing approval to an implant called Revi System. The minimally invasive device, developed by Utah-based medical equipment supplier BlueWind Medical is aimed at treating overactive bladder. It works on neuromodulation therapy to manage symptoms of overactive bladder. The introduction of such novel treatment options in the market is likely to increase the overactive bladder market demand.
Several leading biopharmaceutical companies are actively investing in research and development activities to support the launch of potential treatment therapies for patients suffering from overactive bladder. Such strategic investments are anticipated to bolster the overactive bladder market growth. Moreover, the evolving preference for minimally invasive procedures such as neurostimulation will boost the market growth.
The EMR’s report titled “Overactive Bladder Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Type:
The market segmentation by drug type includes anti-cholinergic drugs, beta-3 adrenergic drugs, botox, neurostimulation, and intravesical instillation. Catering to the diverse needs of the patients, this segmentation offers a variety of pharmacological and non-pharmacological options to treat and manage overactive bladder.
Market Breakup by Disease Type:
The overactive bladder market share is segmented by disease type into idiopathic bladder overactivity and neurogenic bladder overactivity. Idiopathic bladder overactivity is characterized by overactive bladder symptoms without a known underlying cause whereas neurogenic bladder overactivity occurs as a result of underlying neurological conditions.
Market Breakup by Distribution Channel:
The distribution channels in the market include hospital pharmacies, retail pharmacies, online pharmacies, and others. To ensure accessibility and availability of overactive bladder treatments, this segment offers various channels to cater to the growing patient base.
Market Breakup by Region:
Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. North America dominates the regional market, with factors such as the presence of key market players along with a robust healthcare system. The rise in the launch of novel therapies in the region further bolsters the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 2.52% during the forecast period of 2025-2034, driven by the rising incidence of overactive bladder disorders and the introduction of novel treatment therapies in the market.
The rise in novel product launches to treat overactive bladder syndrome is fuelling the demand for the market.
One of the significant trends in the market is the surge in drug and medical device approvals from health regulatory agencies such as the FDA. In August 2023, the United States Food and Drug Administration (FDA) offered marketing approval to BlueWind Medical's Revi System, an implant aimed to treat overactive bladder.
Based on the disease type, the market is segmented into idiopathic bladder overactivity and neurogenic bladder overactivity.
Based on the drug type, the market is segmented into anti-cholinergic drugs, beta-3 adrenergic drugs, Botox, neurostimulation, and intravesical instillation.
The distribution channels in the market include hospital pharmacies, retail pharmacies, online pharmacies, and others.
The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India.
Key players involved in the market are AbbVie Inc., Astellas Pharma Inc., Pfizer Inc., Sumitomo Pharma Co., Ltd, Laborie, Endo International PLC, Hisamitsu Pharmaceutical Co., Inc., Medtronic, and Urovant Sciences.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Disease Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
